76 results
Page 2 of 4
6-K
EX-99.1
gw71whqcx
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
ex6fdpcd
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
9pl 18bn5qdq4bd
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
q1ycy d3355
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
6-K
81w9y
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
6-K
EX-99.2
as1fi6f zb3b9dd
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
drzig7 tizc
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
02jmyjy5 9t
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
z8v42l9a k9s
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.1
0ofz0
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.2
vzoi9r i1gbm
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.2
3jtzrrtdpnoh
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.1
r4t5xe6cvm5ik5tpf3
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.1
mg50nq npi
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am
6-K
d2gnkvj
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am
6-K
EX-1.1
uv8e0xemzpcs
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
d0hz3v
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
4fk6 vm9qxqo9sls
9 Feb 21
Prospectus supplement for primary offering
4:56pm